Chemical Compound

ESORUBICIN HYDROCHLORIDE

CAS Registry Number 63950-06-1

Back to search Request a Quote

Primary Record

ESORUBICIN HYDROCHLORIDE

In stock: 850 g
Purity: 98.4 %
CAS: 63950-06-1

Compound Identifiers & Properties

CAS: 63950-06-1
PubChem CID: 152035
SMILES: C[C@H]1C[C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N.Cl
Canonical SMILES: COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)C[C@H](C)O1.Cl

Names & Synonyms

ESORUBICIN HYDROCHLORIDE
Esorubicin HCl
Deoxydoxorubicin HCI
Esorubicinhydrochlorid
UNII-2UB1JJT82D
Esorubicin hydrochloride [USAN]
2UB1JJT82D
IMI 58
IMI-58
4'-Deoxyadriamycin HCl
4'-Deoxydoxorubicin HCl
RefChem:137875
4'-Deoxyadriamycin hydrochloride
4'-Deoxydoxorubicin hydrochloride
AC1L47JB
SCHEMBL3864
EINECS 264-575-1
Esorubicin hydrochloride (USAN)
C27H29NO10.ClH
C27H29NO10.HCl
NSC 267469
NSC-267469
DTXSID90213783
63950-06-1
CHEMBL2106222
DTXCID20136274
RCFNNLSZHVHCEK-YGCMNLPTSA-N
C27-H29-N-O10.Cl-H
CID152035
ESORUBICIN HYDROCHLORIDE [WHO-DD]
LS-94112
D04067
33813-EP2275420A1
33813-EP2295055A2
33813-EP2295416A2
33813-EP2298748A2
33813-EP2298764A1
33813-EP2298765A1
33813-EP2305642A2
33813-EP2311453A1
Q27255615
(8S,10S)-10-(((2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
(2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride, (2S-(2-alpha(8R*,10R),4-beta,6-beta))-
(7S,9S)-7-[(2S,4R,6S)-4-amino-6-methyloxan-2-yl]oxy-6,9,11-t
(7S,9S)-7-[(2S,4R,6S)-4-amino-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
[2S-[2alpha(8R*,10R*),4beta,6beta]]-10-[(4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
5,12-NAPHTHACENEDIONE, 10-((4-AMINOTETRAHYDRO-6-METHYL-2H-PYRAN-2-YL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-, HYDROCHLORIDE, (2S-(2.ALPHA,(8R*,10R*),4.BETA.,6.BETA))-
5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2S-(2alpha(8R*,10R*),4beta,6beta))-
(7S,9S)-7-[(2S,4R,6S)-4-amino-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
(8S,10S)-10-(((2S,4R,6S)-4-amino-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
(8S,10S)-10-[[(2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione Hydrochloride
(8S,10S)-10-[[(2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl]oxy]-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
(8S,10S)-10-{[(2S,4R,6S)-4-Amino-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione--hydrogen chloride (1/1)
5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-,7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2(2-alpha(8R*,10R*)4-beta,6-beta))-
5,12-NAPHTHACENEDIONE, 10-((4-AMINOTETRAHYDRO-6-METHYL-2H-PYRAN-2-YL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-, HYDROCHLORIDE, (2S-(2.ALPHA,(8R*,10R*),4BETA,6.BETA))-
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride,(2S-(2-alpha(8R*,10R),4-beta,6-beta))-